AMS UK Limited

AMS Labs are a rapidly expanding, innovative primary diagnostics manufacturer based in the United Kingdom, specialising in the development, manufacturing and distribution of an extensive range of IVD Medical Diagnostic and Point of Care Tests for a global market.

ISO 13485:2016

Contact Us

+44 (0)28 2565 6268

Ballymena Business Centre, Galgorm, County Antrim, UK

BT42 1FL

  • LinkedIn Social Icon

In vitro Diagnostic Clinical Chemistry Reagents and Analysers.

Clinical Diagnostic Analysers

AMS UK Ltd. has been in the IVD business for well over a decade with expertise in Clinical Chemistry Quality Controls and calibrators, Rapid tests,  Elisa, Coagulation, Febrile antigens, Latex Serology, Urine strips and Instrumentation.

Currently operating in over 71 countries, AMS UK is an innovative organisation that looks at providing comprehensive and complete solutions to laboratory needs. Our goal is to provide tailor made solutions from instrumentation to reagents and quality controls for laboratories which is made possible by an efficient team of scientists, production managers and support staff. 

Our state of the art facilities in The United Kingdom are world class. The production is streamlined into a single seamless operation from bulk manufacturing to finished kits each with designated cold rooms fitted with modern monitoring systems that ensure product storage at exact temperatures. 

AMS UK Ltd. is actively looking for distributors to be a part of our team of distributors to complete our comprehensive and reliable supply arrangements throughout the world, contact us today for more information -

Creating Better Products to Improve Patient Life 

HEV Hepatitis E Virus Elisa Kits

Hepatitis E is inflammation of the liver caused by infection with the hepatitis E virus. It is one of five known human hepatitis viruses: A, B, C, D, and E.

It can cause your liver to swell but it usually doesn't lead to long-term illness or liver damage like some other forms of hepatitis do. But hepatitis E can be dangerous for pregnant women or anyone with weak immune systems, including the elderly or people who are ill.

Treatment. There is no specific treatment capable of altering the course of acute hepatitis E. As the disease is usually self-limiting, hospitalisation is generally not required. Hospitalisation is required for people with fulminant hepatitis, however, and should also be considered for symptomatic pregnant women.

Serologic Testing. Acute hepatitis E virus (HEV) infection is diagnosed in immunocompetent individuals based on the detection of anti-HEV immunoglobulin M (IgM). The anti-HEV IgM usually starts rising 4 weeks after infection and remains detectable for 2 months after the onset of illness.

Hepatitis E is detected by a blood test that looks for antibodies (protein substances) produced by your body's immune system to fight the virus. The blood test for antibodies should distinguish your infection from hepatitis A or B.

Learn More about our
HEV Elisa Kits

Our new HEV ELISA test provides reliable results at affordable prices to laboratories worldwide.

Email us for more information: